The 2020 edition of China pharmacopoeia will improve the testing of traditional Chinese medicine standards
The national pharmacopoeia commission recently held a small press conference for the preparation of the 2020 edition of the China pharmacopoeia. Conference, the national pharmacopoeia committee secretary general zhang wei said that "pharmacopoeia" 2020 version will further consolidate and expand the achievements of TCM standardization, improve the detection project of traditional Chinese medicine standard, guarantee the safety and efficacy of traditional Chinese medicine (TCM), continue to dominate the international standards.
It is understood that the "pharmacopoeia of China, register for examination and approval of pharmaceutical research has important guiding role, especially for drug quality control and standards in China has a very important role in guidance and specifications. The pharmacopoeia of the preparation work is on the listed drug safety, effectiveness, quality, standard, based on study of full, timely find the listed defects or problems such as imperfect, standard of completion, further improve the level of the quality control of listed drugs.
Zhang wei said that the pharmacopoeia is becoming more and more popular in the world, and has been listed by the world health organization as one of the main references for international pharmacopoeia. "Pharmacopoeia" is an important role to reflect the development of Chinese medicine, to disseminate the culture of Chinese medicine, to show the quality control of Chinese medicine, and to enhance the international influence of Chinese pharmacopoeia.
Zhang wei economic journal - China JingJiWang reporter interview admitted that "drug quality standard system revision is a complex process, and can be adapted to the development of science and technology levels, and to give attention to both to national pharmaceutical industry development level, to establish a scientific, comprehensive, can test, can perform standard, for traditional Chinese medicine composition is relatively complex, the difficulty and the challenge is self-evident".
For Chinese medicinal materials and tablets, the problems such as the submergence of the industry, the adulteration of the industry, the residue of pesticide residues, heavy metals and harmful elements are also discussed. "These problems seriously affect the quality and safety of Chinese medicinal materials, endanger public health, and hinder the healthy development of Chinese medicine industry and traditional Chinese medicine," zhang said.
Zhang wei said that the director of the state administration of food and drug administration, bi jingquan, proposed to crack down on the "hidden rules" of adulterating counterfeit goods. "Pharmacopoeia is the technical regulation of the state to ensure the quality of medicines and the quality of medicines. The standard of pharmacopoeia is the tool or basis for evaluating and evaluating the quality of drugs, so the criterion is the criterion to supervise law enforcement, which is also the basis to ensure the safe and effective drug. It is of great significance for effective supervision and precision regulation to do well in the standard work of drug standards and to make scientific rigor and application.
"We will through the establishment of the most rigorous standards, and constantly improve the traceability system, strengthen the supervision of the whole process of the whole industry chain, etc., ensure the quality of Chinese medicinal materials and yinpian, ensure the safety of the public administration." "Zhang said.
According to the economic daily - China economic network reporter, the 2020 edition of "pharmacopoeia" will further improve the testing program of TCM standards, and comprehensively improve the safety and effectiveness of TCM. The key to improve the quality of Chinese medicine yinpian standard research and develop, establish and perfect Chinese medicine yinpian quality standard: will continue to research and set up heavy metals and harmful elements, pesticide residue and mycotoxins exogenous harmful material such as high sensitivity analysis method and testing technology and its evaluation standard, and comprehensive used for quality control of Chinese herbal medicine and yinpian, and enhance the level of Chinese medicine safety control; Establish and improve the effective component determination, multi-component determination and feature/fingerprint detection technology, and explore the bioactivity evaluation method to comprehensively improve the control level of Chinese medicine.